Director, Global HEOR Rare Disease Immunology reporting to Montserrat Vera-Llonch was filled for Ionis. This is a critical and significant role as the commercial function… Continue Reading →
Ionis Pharmaceuticals has a 30-year track record of perfecting and advancing RNA-targeted drug discovery and development and is now expanding its commercialization capabilities. That expansion… Continue Reading →